세계의 척수 손상 치료 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global Spinal Cord Trauma Treatment Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Spinal Cord Trauma Treatment Market Size (2024E): US$ 2,196.8 Mn
• Projected Market Value (2031F): US$ 5,429.9 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 13.8%

Spinal Cord Trauma Treatment Market - Report Scope:

The Spinal Cord Trauma Treatment market involves a variety of therapies designed to treat individuals suffering from spinal cord injuries. These injuries can be complete or partial, resulting from trauma such as accidents or falls. The market includes treatment methods like corticosteroid administration, surgery, and spinal traction, which aim to reduce damage, enhance recovery, and improve the quality of life for patients. The market is driven by advancements in medical technology, an increase in the incidence of spinal cord injuries, and growing awareness regarding effective treatment options.

Market Growth Drivers:

Several key factors are driving the growth of the global Spinal Cord Trauma Treatment market. The rising number of accidents and falls leading to spinal cord injuries is a significant factor contributing to market growth. Additionally, continuous advancements in medical research and the development of new treatment methods, including gene therapy and stem cell treatments, are propelling market expansion. The increased focus on improving patient outcomes and enhancing rehabilitation practices also plays a key role in market growth. Furthermore, rising healthcare awareness and improved accessibility to advanced medical treatments in hospitals and trauma centers are fueling the demand for spinal cord trauma treatments.

Market Restraints:

Despite the promising growth, the Spinal Cord Trauma Treatment market faces challenges such as the high cost of advanced treatments and therapies, particularly for regenerative medicines and surgeries. The complexity of spinal cord injury treatments, as well as the long recovery periods, can pose significant challenges to both patients and healthcare providers. Moreover, limited availability of specialized trauma centers in certain regions and the need for skilled professionals may restrict access to effective treatments, hindering market growth.

Market Opportunities:

The Spinal Cord Trauma Treatment market presents substantial growth opportunities driven by ongoing advancements in medical technologies, such as personalized medicine, neurostimulation devices, and regenerative therapies. The increasing availability of innovative treatments, including stem cell therapies and gene therapies, is expected to drive market growth. Additionally, expanding healthcare infrastructures in emerging economies, increased government investments in medical research, and collaborations between pharmaceutical companies and biotech firms for new drug development offer new growth opportunities. Raising awareness and providing better access to treatment in underdeveloped and rural areas can also create significant growth prospects for the market.

Key Questions Answered in the Report:

• What are the primary factors driving global growth in the Spinal Cord Trauma Treatment market?
• What are the key treatment types witnessing the highest demand across different regions?
• How are advancements in spinal cord injury treatments influencing market dynamics?
• Who are the major players in the Spinal Cord Trauma Treatment market, and what strategies are they using to remain competitive?
• What are the emerging trends and future prospects in the Spinal Cord Trauma Treatment market?

Competitive Intelligence and Business Strategy:

Leading players in the global Spinal Cord Trauma Treatment market, including Acorda Therapeutics, Inc., Asterias Biotherapeutics, and ReNetX Bio, are focusing on research and development, innovative treatment approaches, and strategic partnerships to strengthen their market positions. These companies are investing in clinical trials for novel therapies, exploring stem cell research, and leveraging new technologies to develop cutting-edge solutions for spinal cord trauma. Collaborations with hospitals, trauma centers, and rehabilitation centers are essential to improve treatment outcomes and enhance patient accessibility to these advanced treatments.

Key Companies Profiled:

• Acorda Therapeutics, Inc.
• Asterias Biotherapeutics
• ReNetX Bio.
• BioArctic AB
• BioTime, Inc.
• InVivo Therapeutics
• Kringle Pharma, Inc.
• Novartis AG
• Pfizer Inc.
• Pharmicell Co. Ltd.
• Vertex Pharmaceuticals Inc.
• Bioaxone Biosciences, Inc.
• Others

Spinal Cord Trauma Treatment Industry Research by Category:

By Treatment Type:

• Corticosteroid
• Surgery
• Spinal Traction

By Injury Type:

• Complete Spinal Cord Injuries
• Partial Spinal Cord Injuries

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

By End User:

• Hospitals
• Trauma Centers

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Spinal Cord Trauma Treatment Market Opportunity Analysis

• 3.1. Macro-Economic Factors
• 3.2. Opportunity Analysis
• 3.3. Epidemiology Analysis
• 3.4. Pipeline Snapshot

4. North America Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 4.1. Market Snapshot
• 4.2. Introduction
• 4.3. Regional Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Trends
• 4.4. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019-2023
  • 4.4.1. U.S.
  • 4.4.2. Canada
• 4.5. Market Size (US$ Mn ) Forecast By Country, 2024-2031
  • 4.5.1. U.S.
  • 4.5.2. Canada
• 4.6. Historical Market Size (US$ Mn ) Trend Analysis By Treatment Type, 2019-2023
  • 4.6.1. Corticosteroid
  • 4.6.2. Surgery
  • 4.6.3. Spinal Traction
• 4.7. Market Size (US$ Mn ) Forecast By Treatment Type, 2024-2031
  • 4.7.1. Corticosteroid
  • 4.7.2. Surgery
  • 4.7.3. Spinal Traction
• 4.8. Market Size (US$ Mn ) Trend Analysis By Injury Type, 2019-2023
  • 4.8.1. Complete Spinal Cord Injuries
  • 4.8.2. Partial Spinal Cord Injuries
• 4.9. Market Size (US$ Mn ) Forecast By Injury Type, 2024-2031
  • 4.9.1. Complete Spinal Cord Injuries
  • 4.9.2. Partial Spinal Cord Injuries
• 4.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 4.10.1. Hospitals
  • 4.10.2. Trauma Centers
• 4.11. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 4.11.1. Hospitals
  • 4.11.2. Trauma Centers
• 4.12. Market Attractiveness Analysis
  • 4.12.1. By Country
  • 4.12.2. By Treatment Type
  • 4.12.3. By Injury Type
  • 4.12.4. By End User

5. Latin America Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 5.1. Market Snapshot
• 5.2. Introduction
• 5.3. Regional Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Trends
• 5.4. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019-2023
  • 5.4.1. Brazil
  • 5.4.2. Mexico
  • 5.4.3. Rest of Latin America
• 5.5. Market Size (US$ Mn ) Forecast By Country, 2024-2031
  • 5.5.1. Brazil
  • 5.5.2. Mexico
  • 5.5.3. Rest of Latin America
• 5.6. Historical Market Size (US$ Mn ) Trend Analysis By Treatment Type, 2019-2023
  • 5.6.1. Corticosteroid
  • 5.6.2. Surgery
  • 5.6.3. Spinal Traction
• 5.7. Market Size (US$ Mn ) Forecast By Treatment Type, 2024-2031
  • 5.7.1. Corticosteroid
  • 5.7.2. Surgery
  • 5.7.3. Spinal Traction
• 5.8. Market Size (US$ Mn ) Trend Analysis By Injury Type, 2019-2023
  • 5.8.1. Complete Spinal Cord Injuries
  • 5.8.2. Partial Spinal Cord Injuries
• 5.9. Market Size (US$ Mn ) Forecast By Injury Type, 2024-2031
  • 5.9.1. Complete Spinal Cord Injuries
  • 5.9.2. Partial Spinal Cord Injuries
• 5.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 5.10.1. Hospitals
  • 5.10.2. Trauma Centers
• 5.11. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 5.11.1. Hospitals
  • 5.11.2. Trauma Centers
• 5.12. Market Attractiveness Analysis
  • 5.12.1. By Country
  • 5.12.2. By Treatment Type
  • 5.12.3. By Injury Type
  • 5.12.4. By End User

6. Europe Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 6.1. Market Snapshot
• 6.2. Introduction
• 6.3. Regional Market Dynamics
  • 6.3.1. Drivers
  • 6.3.2. Restraints
  • 6.3.3. Trends
• 6.4. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019-2023
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Rest of Europe
• 6.5. Market Size (US$ Mn ) Forecast By Country, 2024-2031
  • 6.5.1. Germany
  • 6.5.2. France
  • 6.5.3. U.K.
  • 6.5.4. Italy
  • 6.5.5. Spain
  • 6.5.6. Rest of Europe
• 6.6. Historical Market Size (US$ Mn ) Trend Analysis By Treatment Type, 2019-2023
  • 6.6.1. Corticosteroid
  • 6.6.2. Surgery
  • 6.6.3. Spinal Traction
• 6.7. Market Size (US$ Mn ) Forecast By Treatment Type, 2024-2031
  • 6.7.1. Corticosteroid
  • 6.7.2. Surgery
  • 6.7.3. Spinal Traction
• 6.8. Market Size (US$ Mn ) Trend Analysis By Injury Type, 2019-2023
  • 6.8.1. Complete Spinal Cord Injuries
  • 6.8.2. Partial Spinal Cord Injuries
• 6.9. Market Size (US$ Mn ) Forecast By Injury Type, 2024-2031
  • 6.9.1. Complete Spinal Cord Injuries
  • 6.9.2. Partial Spinal Cord Injuries
• 6.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 6.10.1. Hospitals
  • 6.10.2. Trauma Centers
• 6.11. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 6.11.1. Hospitals
  • 6.11.2. Trauma Centers
• 6.12. Market Attractiveness Analysis
  • 6.12.1. By Country
  • 6.12.2. By Treatment Type
  • 6.12.3. By Injury Type
  • 6.12.4. By End User

7. Asia Pacific Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 7.1. Market Snapshot
• 7.2. Introduction
• 7.3. Regional Market Dynamics
  • 7.3.1. Drivers
  • 7.3.2. Restraints
  • 7.3.3. Trends
• 7.4. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019-2023
  • 7.4.1. China
  • 7.4.2. India
  • 7.4.3. Japan
  • 7.4.4. Australia and New Zealand
  • 7.4.5. Rest of Asia Pacific
• 7.5. Market Size (US$ Mn ) Forecast By Country, 2024-2031
  • 7.5.1. China
  • 7.5.2. India
  • 7.5.3. Japan
  • 7.5.4. Australia and New Zealand
  • 7.5.5. Rest of Asia Pacific
• 7.6. Historical Market Size (US$ Mn ) Trend Analysis By Treatment Type, 2019-2023
  • 7.6.1. Corticosteroid
  • 7.6.2. Surgery
  • 7.6.3. Spinal Traction
• 7.7. Market Size (US$ Mn ) Forecast By Treatment Type, 2024-2031
  • 7.7.1. Corticosteroid
  • 7.7.2. Surgery
  • 7.7.3. Spinal Traction
• 7.8. Market Size (US$ Mn ) Trend Analysis By Injury Type, 2019-2023
  • 7.8.1. Complete Spinal Cord Injuries
  • 7.8.2. Partial Spinal Cord Injuries
• 7.9. Market Size (US$ Mn ) Forecast By Injury Type, 2024-2031
  • 7.9.1. Complete Spinal Cord Injuries
  • 7.9.2. Partial Spinal Cord Injuries
• 7.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 7.10.1. Hospitals
  • 7.10.2. Trauma Centers
• 7.11. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 7.11.1. Hospitals
  • 7.11.2. Trauma Centers
• 7.12. Market Attractiveness Analysis
  • 7.12.1. By Country
  • 7.12.2. By Treatment Type
  • 7.12.3. By Injury Type
  • 7.12.4. By End User

8. Middle East & Africa Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 8.1. Market Snapshot
• 8.2. Introduction
• 8.3. Regional Market Dynamics
  • 8.3.1. Drivers
  • 8.3.2. Restraints
  • 8.3.3. Trends
• 8.4. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019-2023
  • 8.4.1. South Africa
  • 8.4.2. GCC Countries
  • 8.4.3. Turkey
  • 8.4.4. Rest of MEA
• 8.5. Market Size (US$ Mn ) Forecast By Country, 2024-2031
  • 8.5.1. South Africa
  • 8.5.2. GCC Countries
  • 8.5.3. Turkey
  • 8.5.4. Rest of MEA
• 8.6. Historical Market Size (US$ Mn ) Trend Analysis By Treatment Type, 2019-2023
  • 8.6.1. Corticosteroid
  • 8.6.2. Surgery
  • 8.6.3. Spinal Traction
• 8.7. Market Size (US$ Mn ) Forecast By Treatment Type, 2024-2031
  • 8.7.1. Corticosteroid
  • 8.7.2. Surgery
  • 8.7.3. Spinal Traction
• 8.8. Market Size (US$ Mn ) Trend Analysis By Injury Type, 2019-2023
  • 8.8.1. Complete Spinal Cord Injuries
  • 8.8.2. Partial Spinal Cord Injuries
• 8.9. Market Size (US$ Mn ) Forecast By Injury Type, 2024-2031
  • 8.9.1. Complete Spinal Cord Injuries
  • 8.9.2. Partial Spinal Cord Injuries
• 8.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 8.10.1. Hospitals
  • 8.10.2. Trauma Centers
• 8.11. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 8.11.1. Hospitals
  • 8.11.2. Trauma Centers
• 8.12. Market Attractiveness Analysis
  • 8.12.1. By Country
  • 8.12.2. By Treatment Type
  • 8.12.3. By Injury Type
  • 8.12.4. By End User

9. Competition Landscape

• 9.1. Competition Dashboard
• 9.2. Company Profiles (Details - Overview, Financials, Strategy, SWOT)
  • 9.2.1. Acorda Therapeutics, Inc.
  • 9.2.2. Asterias Biotherapeutics
  • 9.2.3. ReNetX Bio.
  • 9.2.4. BioArctic AB
  • 9.2.5. BioTime, Inc.
  • 9.2.6. InVivo Therapeutics
  • 9.2.7. Kringle Pharma, Inc.
  • 9.2.8. Novartis AG
  • 9.2.9. Pfizer Inc.
  • 9.2.10. Pharmicell Co. Ltd.
  • 9.2.11. Vertex Pharmaceuticals Inc.
  • 9.2.12. Bioaxone Biosciences, Inc.

10. Global Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 10.1. Introduction/Key Findings
• 10.2. Historical Market Size (US$ Mn ) Trend Analysis By Region, 2019-2023
  • 10.2.1. North America
  • 10.2.2. Latin America
  • 10.2.3. Europe
  • 10.2.4. Asia Pacific
  • 10.2.5. Middle East & Africa
• 10.3. Market Size (US$ Mn ) Forecast By Region, 2024-2031
  • 10.3.1. North America
  • 10.3.2. Latin America
  • 10.3.3. Europe
  • 10.3.4. Asia Pacific
  • 10.3.5. Middle East & Africa
• 10.4. Market Attractiveness Analysis By Region

11. Global Spinal Cord Trauma Treatment Analysis 2019-2023 and Forecast 2024-2031, By Treatment Type

• 11.1. Introduction/Key Findings
• 11.2. Historical Market Size (US$ Mn ) and Volume Trend Analysis By Treatment Type, 2019-2023
  • 11.2.1. Corticosteroid
  • 11.2.2. Surgery
  • 11.2.3. Spinal Traction
• 11.3. Market Size (US$ Mn ) and Volume Forecast By Treatment Type, 2024-2031
  • 11.3.1. Corticosteroid
  • 11.3.2. Surgery
  • 11.3.3. Spinal Traction
• 11.4. Market Attractiveness Analysis By Treatment Type

12. Global Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Injury Type

• 12.1. Introduction/Key Findings
• 12.2. Historical Market Size (US$ Mn ) Trend Analysis By Injury Type , 2019-2023
  • 12.2.1. Complete Spinal Cord Injuries
  • 12.2.2. Partial Spinal Cord Injuries
• 12.3. Market Size (US$ Mn ) Forecast By Injury Type , 2024-2031
  • 12.3.1. Complete Spinal Cord Injuries
  • 12.3.2. Partial Spinal Cord Injuries
• 12.4. Market Attractiveness Analysis By Injury Type

13. Global Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By End User

• 13.1. Introduction/Key Findings
• 13.2. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019-2023
  • 13.2.1. Hospitals
  • 13.2.2. Trauma Centers
• 13.3. Market Size (US$ Mn ) Forecast By End User, 2024-2031
  • 13.3.1. Hospitals
  • 13.3.2. Trauma Centers
• 13.4. Market Attractiveness Analysis By End User

14. Global Spinal Cord Trauma Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 14.1. Market Size and Y-o-Y Growth
• 14.2. Absolute $ Opportunity

15. Assumptions and Acronyms Used

16. Research Methodology